1-6 of 6
Hirofumi Mukai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer

Open Access
Subject Area:
Oncology
Takuya Kawahara, Kojiro Shimozuma, Takeru Shiroiwa, Yasuhiro Hagiwara, Yukari Uemura, Takanori Watanabe, Naruto Taira, Takashi Fukuda, Yasuo Ohashi, Hirofumi Mukai
Journal: Oncology
Oncology (2018) 94 (2): 107–115.
https://doi.org/10.1159/000484142
Published Online: 17 November 2017
View articletitled, Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer
Open the PDF for Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer in another window
Journal Articles

The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer

Open Access
Subject Area:
Oncology
Hirofumi Mukai, Yasuhiro Hagiwara, Kentaro Imi, Hirotsugu Isaka, Kenichi Watanabe, Yutaka Matsuyama, for the SELECT BC Study Group
Journal: Oncology
Oncology (2017) 93 (5): 315–322.
https://doi.org/10.1159/000479033
Published Online: 24 August 2017
View articletitled, The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer
Open the PDF for The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer in another window
Journal Articles

Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer

Available to Purchase
Subject Area:
Oncology
Takeshi Yamaguchi, Hirofumi Mukai, Satoshi Yamashita, Satoshi Fujii, Toshikazu Ushijima
Journal: Oncology
Oncology (2015) 88 (6): 377–384.
https://doi.org/10.1159/000369904
Published Online: 14 January 2015
View articletitled, Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer
Open the PDF for Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer in another window
Journal Articles

Final Results of a Safety and Efficacy Trial of Preoperative Sequential Chemoradiation Therapy for the Nonsurgical Treatment of Early Breast Cancer: Japan Clinical Oncology Group Study JCOG0306

Available to Purchase
Subject Area:
Oncology
Hirofumi Mukai, Toru Watanabe, Michihide Mitsumori, Hitoshi Tsuda, Seigo Nakamura, Norikazu Masuda, Naohito Yamamoto, Taro Shibata, Akihiro Sato, Hiroji Iwata, Kenjiro Aogi
Journal: Oncology
Oncology (2013) 85 (6): 336–341.
https://doi.org/10.1159/000355196
Published Online: 12 November 2013
View articletitled, Final Results of a Safety and Efficacy Trial of Preoperative Sequential Chemoradiation Therapy for the Nonsurgical Treatment of Early Breast Cancer: Japan Clinical Oncology Group Study JCOG0306
Open the PDF for Final Results of a Safety and Efficacy Trial of Preoperative Sequential Chemoradiation Therapy for the Nonsurgical Treatment of Early Breast Cancer: Japan Clinical Oncology Group Study JCOG0306 in another window
Journal Articles

Retrospective Analysis of Risk Factors for Central Nervous System Metastases in Operable Breast Cancer: Effects of Biologic Subtype and Ki67 Overexpression on Survival

Available to Purchase
Subject Area:
Oncology
Mikiya Ishihara, Hirofumi Mukai, Shunji Nagai, Masakatsu Onozawa, Keiji Nihei, Toshiyuki Shimada, Noriaki Wada
Journal: Oncology
Oncology (2013) 84 (3): 135–140.
https://doi.org/10.1159/000345321
Published Online: 11 December 2012
View articletitled, Retrospective Analysis of Risk Factors for Central Nervous System Metastases in Operable Breast Cancer: Effects of Biologic Subtype and Ki67 Overexpression on Survival
Open the PDF for Retrospective Analysis of Risk Factors for Central Nervous System Metastases in Operable Breast Cancer: Effects of Biologic Subtype and Ki67 Overexpression on Survival in another window
Journal Articles

Prognostic Impact of Ki-67 Overexpression in Subgroups Categorized according to St. Gallen with Early Stage Breast Cancer

Available to Purchase
Subject Area:
Oncology
Nobuaki Matsubara, Hirofumi Mukai, Kuniaki Itoh, Shunji Nagai
Journal: Oncology
Oncology (2012) 81 (5-6): 345–352.
https://doi.org/10.1159/000334920
Published Online: 13 January 2012
View articletitled, Prognostic Impact of Ki-67 Overexpression in Subgroups Categorized according to St. Gallen with Early Stage Breast Cancer
Open the PDF for Prognostic Impact of Ki-67 Overexpression in Subgroups Categorized according to St. Gallen with Early Stage Breast Cancer in another window